Fischer Medical Ventures Ltd: Stock Analysis & Fundamentals

Updated this week

Fischer Medical Ventures Ltd (Chemicals - Inorganic) — fundamental analysis, earnings data, and key metrics. PE: 63.5. ROE: 0.7%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

💪Debt reduced 65% YoY — balance sheet strengthening

👔Promoter stake down 13.1% this quarter

🌐FII stake increased 0.5% this quarter

Key Numbers

Current Price

₹39

Dividend Yield

0.01%

Market Cap

2.5K Cr

Valuation

N/A

Other Top Chemicals - Inorganic Stocks Beating Nifty 500

Archean Chemical Industries Ltd

Weak

+26.7%

← Back to Chemicals - Inorganic Dashboard

Frequently Asked Questions: Fischer Medical Ventures Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Fischer Medical Ventures Ltd's latest quarterly results?

Fischer Medical Ventures Ltd's latest quarterly results (Dec 2025) show

Revenue Growth YoY: +741.7%
Operating Margin: 21.0%

What is Fischer Medical Ventures Ltd's current PE ratio?

Fischer Medical Ventures Ltd's current PE ratio is 63.5x.

Current PE: 63.5x
Market Cap: 2.5K Cr
Dividend Yield: 0.01%

What is Fischer Medical Ventures Ltd's price-to-book ratio?

Fischer Medical Ventures Ltd's price-to-book ratio is 7.0x.

Price-to-Book (P/B): 7.0x
Book Value per Share: ₹6
Current Price: ₹39

Is Fischer Medical Ventures Ltd a fundamentally strong company?

Fischer Medical Ventures Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 1.0%

Is Fischer Medical Ventures Ltd debt free?

Fischer Medical Ventures Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹30 Cr

What is Fischer Medical Ventures Ltd's return on equity (ROE) and ROCE?

Fischer Medical Ventures Ltd's return ratios over recent years

FY2023: ROCE 8.7%
FY2024: ROCE 5.0%
FY2025: ROCE 1.0%

Is Fischer Medical Ventures Ltd's cash flow positive?

Fischer Medical Ventures Ltd's operating cash flow is negative (FY2025).

Cash from Operations (CFO): ₹-87 Cr
Free Cash Flow (FCF): ₹-212 Cr
CFO/PAT Ratio: -8700% (weak cash conversion)

What is Fischer Medical Ventures Ltd's dividend yield?

Fischer Medical Ventures Ltd's current dividend yield is 0.01%.

Dividend Yield: 0.01%
Current Price: ₹39

Who holds Fischer Medical Ventures Ltd shares — promoters, FII, DII?

Fischer Medical Ventures Ltd's shareholding pattern (Dec 2025)

Promoters: 61.8%
FII (Foreign): 4.8%
DII (Domestic): 1.4%
Public: 32.0%

Is promoter holding increasing or decreasing in Fischer Medical Ventures Ltd?

Fischer Medical Ventures Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 61.8% (Dec 2025)
Previous Quarter: 61.8% (Sep 2025)
Change: 0.00% (stable)

Is Fischer Medical Ventures Ltd a new momentum entry or an established outperformer?

Fischer Medical Ventures Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Fischer Medical Ventures Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Fischer Medical Ventures Ltd may be worth studying

Currently showing mixed signals — monitor for clearer trend confirmation

What is the investment thesis for Fischer Medical Ventures Ltd?

Fischer Medical Ventures Ltd investment thesis summary:

What is the future outlook for Fischer Medical Ventures Ltd?

Fischer Medical Ventures Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.